The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome
Status:
Unknown status
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of ProAlgaZyme in increasing
levels of HDL 'good' cholesterol and decreasing total cholesterol and C-reactive protein in
patients with Metabolic Syndrome.